Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Corcept Therapeutics (CORT) stock shot up over 100% yesterday as markets reacted to the company’s announcement of promising outcomes from its ...

Corcept Therapeutics' stock surged over 80% after its Phase 3 ROSELLA trial met its primary goal, showing promise for relacorilant in treating platinum-resistant ovarian cancer. The ROSELLA trial ...

TYLER, Texas (KLTV) - An East Texan celebrated her 101st birthday today at the Wesley House Assisted Living Center in Gilmer. It wasn’t like any other birthday for Rosella Nix, a resident at the ...

Rosella (Ryer) Kreidler, 92, passed away peacefully on Wednesday, April 9, 2025, at The Residence at Fitz Farm. Born in Dallastown on November 18, 1932, she was the daughter of the late Jacob and ...

Results will support a New Drug Application (NDA) in the United States and a Marketing Authorization Application (MAA) in Europe Relacorilant plus nab-paclitaxel has the potential to become a new ...